Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Gregory Glenn
Age : 67
Public asset : 255,231 USD
Country of residence : Unknown
Linked companies : Novavax, Inc.

Biography of Gregory Glenn 
Gregory M. Glenn founded Intercell USA, Inc. Dr. Glenn is President-Research & Development at Novavax, Inc. He previously occupied the position of Chief Scientific Officer for Intercell AG, Chief Scientific Officer & Senior Vice President at Intercell USA, Inc., Research Scientist at Walter Reed Army Institute of Research and Associate-International Health at Johns Hopkins Bloomberg School of Public Health. Dr. Glenn received an undergraduate degree from Whitman College and a doctorate from Oral Roberts University.


Current positions of Gregory Glenn 
Holdings of Gregory Glenn 
Gregory Glenn : Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/27ELON MUSK : Musk sued by Twitter investors for stock 'manipulation' during takeover bid
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/20LUCA DE MEO : Renault boss Luca de Meo could return to Japan in June - source
RE
More news


© 2022 People and Ownership :   
Gregory Glenn : Connections 


Latest news about Gregory Glenn 
05/11TRANSCRIPT : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 05:20 PM
CI
04/20Novavax Says Early COVID-Influenza Combo Vaccine Data 'Encouraging'
MT
02/10TRANSCRIPT : Novavax, Inc. - Special Call
CI
01/10TRANSCRIPT : Novavax, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 09:00 AM
CI
2021Novavax COVID-19 Vaccine Shows Immune Response Against Omicron Variant
MT
2021TRANSCRIPT : Novavax, Inc. - Special Call
CI
More news